Yip Stephen, Jeraj Robert
Department of Physics, University of Wisconsin, Madison, WI, USA.
Phys Med Biol. 2014 Mar 21;59(6):1501-14. doi: 10.1088/0031-9155/59/6/1501. Epub 2014 Mar 5.
Accurate skeleton registration is necessary to match corresponding metastatic bone lesions for response assessment over multiple scans. In articulated registration (ART), whole-body skeletons are registered by auto-segmenting individual bones, then rigidly aligning them. Performance and robustness of the ART in lesion matching were evaluated and compared to other commonly used registration techniques. Sixteen prostate cancer patients were treated either with molecular targeted therapy or chemotherapy. Ten out of the 16 patients underwent the double baseline whole-body [F-18]NaF PET/CT scans for test-retest (TRT) evaluation. Twelve of the 16 patients underwent pre- and mid-treatment [F-18]NaF PET/CT scans. Skeletons at different time points were registered using ART, rigid, and deformable (DR) registration algorithms. The corresponding lesions were contoured and identified on successive PET images based on including the voxels with the standardized uptake value over 15. Each algorithm was evaluated for its ability to accurately align corresponding lesions via skeleton registration. A lesion matching score (MS) was measured for each lesion, which quantified the per cent overlap between the lesion's two corresponding contours. Three separate sensitivity studies were conducted to investigate the robustness of ART in matching: sensitivity of lesion matching to various contouring threshold levels, effects of imperfections in the bone auto-segmentation and sensitivity of mis-registration. The performance of ART (MS = 82% for both datasets, p ≪ 0.001) in lesion matching was significantly better than rigid (MS(TRT)=53%, MS(Response)= 46%) and DR (MS(TRT)=46%, MS(Response)=45%) algorithms. Neither varying threshold levels for lesion contouring nor imperfect bone segmentation had significant (p~0.10) impact on the ART matching performance as the MS remained unchanged. Despite the mis-registration reduced MS for ART, as low as 67% (p ≪ 0.001), the performance remained to be superior to the rigid and DR algorithms. ART is not only robust to contouring threshold levels for bone lesions, but also outperforms rigid and DR algorithms in lesion matching. ART therefore enables the study of TRT variability and treatment assessment of individual bone lesions.
为了在多次扫描中匹配相应的转移性骨病变以进行疗效评估,准确的骨骼配准是必要的。在关节配准(ART)中,通过自动分割单个骨骼,然后将它们刚性对齐来对全身骨骼进行配准。评估了ART在病变匹配中的性能和稳健性,并与其他常用的配准技术进行了比较。16名前列腺癌患者接受了分子靶向治疗或化疗。16名患者中有10名接受了双基线全身[F-18]NaF PET/CT扫描以进行重测(TRT)评估。16名患者中有12名接受了治疗前和治疗中期的[F-18]NaF PET/CT扫描。使用ART、刚性和可变形(DR)配准算法对不同时间点的骨骼进行配准。基于包括标准化摄取值超过15的体素,在连续的PET图像上勾勒并识别相应的病变。评估了每种算法通过骨骼配准准确对齐相应病变 的能力。为每个病变测量病变匹配分数(MS),该分数量化了病变的两个相应轮廓之间的重叠百分比。进行了三项单独的敏感性研究以研究ART在匹配中的稳健性:病变匹配对各种轮廓阈值水平的敏感性、骨自动分割中的缺陷的影响以及配准错误的敏感性。ART在病变匹配中的性能(两个数据集的MS = 82%,p≪0.001)明显优于刚性(MS(TRT)=53%,MS(反应)=46%)和DR(MS(TRT)=46%,MS(反应)=45%)算法。由于MS保持不变,病变轮廓的不同阈值水平或不完美的骨分割对ART匹配性能均无显著(p~0.10)影响。尽管配准错误会降低ART的MS,低至67%(p≪0.001),但其性能仍优于刚性和DR算法。ART不仅对骨病变的轮廓阈值水平具有稳健性,而且在病变匹配方面优于刚性和DR算法。因此,ART能够研究TRT变异性并评估个体骨病变的治疗效果。